Check out the latest issue which features content on #diabetes prevention, #cannabis and #psychedelics gaining clinical acceptance, the latest industry updates, and more. buff.ly/3CrCy8o

Researchers determined the association between #insurance type and #HIV outcomes, including antiretroviral adherence and health-related quality of life. buff.ly/3fFGrgT

“Coverage appears to be more likely for prescription-only digital therapeutics; however, challenges with proof of long-term benefit, patient adherence, and fulfillment remain,” said authors of a poster presented at #AMCPNexus 2022. buff.ly/3rSZA1S

Using claims data from #MedicareAdvantage, Managed Medicaid, and commercial insurance plans, researchers identified the #costs associated with severe, persistent #asthma. buff.ly/3yXCM4S

Gary Owens, MD, president, Gary Owens Associates, describes the current #treatment landscape for spinal muscular atrophy and the #challenges payers face when covering this patient population. buff.ly/3F8aeJN

“Availability of lower cost therapies may considerably decrease the #economic burden on these patients and the #healthcare systems,” wrote researchers. buff.ly/3D6ABx1

The Centers for Medicare & Medicaid Services and the US Department of Health and Human Services are expanding access to #dentalcare, #cancer screening coverage, and behavioral health #care buff.ly/3WmEMxP

In this commentary, Steven McNeilly offers insight into a health system's approach to value-based #care including advice for improving metrics and relationships with payers and providers. buff.ly/3E5glgY

Study authors examined the efficacy and safety of a 24-week regimen of CTP-543 in #patients with chronic, moderate-to-severe alopecia areata. buff.ly/3NWcjv0

Researchers examined the impact of #medication and symptom control on real-world quality of life in patients with #narcolepsy during 5 years of follow-up. buff.ly/3A8rwTO

Study authors examined comorbidities and potential extaneural manifestations associated with spinal muscular atrophy in treatment-naive patients. buff.ly/3UUUyP2

Between 2012 and 2017, pediatric hospitalizations for atopic dermatitis predominantly involved children covered by #PublicHealth plans, findings show. buff.ly/3EnZepB

In addition to the #Economic burden of the disease, researchers also reported the humanistic burden associated with pediatric-onset multiple sclerosis. buff.ly/3i7Ri4B

#ICYMI There is still time to register for tomorrow's Managed Care Considerations webinar happening at 1 p.m. buff.ly/3GU1pUX

In the second part of this roundtable, Edmund Pezalla, MD, MPH; Adam Kittai, MD; Farrukh Awan, MD; and Jeffrey Dunn, PharmD, MBA, discuss cost and access challenges for treating #patients with zanubrutinib. buff.ly/3EMxPQ2

Happening soon! There's still time to register for today's webinar on managed care considerations for the treatment of tardive dyskinesia. Can't make it? Check out the other date below! buff.ly/3UzmQOt

Patients with relapsing/remitting multiple sclerosis reported improvements in #medication satisfaction, fatigue, and other measures after switching from other therapies to a monoclonal antibody. buff.ly/3OJabXL

Researchers assessed potential factors driving differences in #disease burden between African American and White patients with multiple sclerosis. buff.ly/3GSLhDa

There's still time to register for the managed care considerations webinar on Addressing the Burdens of Alzheimer's Disease. Check out the two dates and times below! buff.ly/3iprwsF

Study authors examined the safety and effectiveness of pitolisant in #patients with type I narcolepsy who did not tolerate or respond to previous treatments. buff.ly/3EJkOoL